Osaic Holdings’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.6K | Sell |
20,026
-12,974
| -39% | -$27.6K | ﹤0.01% | 4814 |
|
|
2025
Q1 | $48.2K | Buy |
33,000
+12,310
| +59% | +$18K | ﹤0.01% | 4730 |
|
|
2024
Q4 | $44.1K | Buy |
20,690
+2,240
| +12% | +$4.77K | ﹤0.01% | 4780 |
|
|
2024
Q3 | $51.7K | Sell |
18,450
-301
| -2% | -$843 | ﹤0.01% | 4703 |
|
|
2024
Q2 | $43.7K | Buy |
18,751
+8,357
| +80% | +$19.5K | ﹤0.01% | 4764 |
|
|
2024
Q1 | $46.5K | Sell |
10,394
-1,605
| -13% | -$7.17K | ﹤0.01% | 4788 |
|
|
2023
Q4 | $38.5K | Sell |
11,999
-201
| -2% | -$645 | ﹤0.01% | 5060 |
|
|
2023
Q3 | $38.7K | Buy |
12,200
+8,780
| +257% | +$27.8K | ﹤0.01% | 5160 |
|
|
2023
Q2 | $17K | Sell |
3,420
-4,745
| -58% | -$23.6K | ﹤0.01% | 5653 |
|
|
2023
Q1 | $40.3K | Sell |
8,165
-4,423
| -35% | -$21.8K | ﹤0.01% | 5084 |
|
|
2022
Q4 | $79K | Sell |
12,588
-5,521
| -30% | -$34.6K | ﹤0.01% | 4617 |
|
|
2022
Q3 | $196K | Sell |
18,109
-9,529
| -34% | -$103K | ﹤0.01% | 3762 |
|
|
2022
Q2 | $315K | Buy |
27,638
+16,270
| +143% | +$185K | ﹤0.01% | 3378 |
|
|
2022
Q1 | $103K | Buy |
11,368
+640
| +6% | +$5.8K | ﹤0.01% | 4574 |
|
|
2021
Q4 | $160K | Buy |
10,728
+359
| +3% | +$5.35K | ﹤0.01% | 4154 |
|
|
2021
Q3 | $266K | Buy |
10,369
+2,231
| +27% | +$57.2K | ﹤0.01% | 3643 |
|
|
2021
Q2 | $212K | Buy |
8,138
+2,107
| +35% | +$54.9K | ﹤0.01% | 3817 |
|
|
2021
Q1 | $214K | Buy |
6,031
+1,862
| +45% | +$66.1K | ﹤0.01% | 3665 |
|
|
2020
Q4 | $105K | Buy |
4,169
+2,369
| +132% | +$59.7K | ﹤0.01% | 3991 |
|
|
2020
Q3 | $68K | Buy |
1,800
+124
| +7% | +$4.68K | ﹤0.01% | 4082 |
|
|
2020
Q2 | $72K | Sell |
1,676
-1
| -0.1% | -$43 | ﹤0.01% | 3911 |
|
|
2020
Q1 | $33K | Buy |
+1,677
| New | +$33K | ﹤0.01% | 4266 |
|